致信至未来-新ARNI的临床价值与发展研讨
Letter to the Future - Clinical Value and Development of the New ARNI
Letter to the Future - Clinical Value and Development of the New ARNI
2024年11月21日 星期四
|
16:30-18:00 304 |
|---|
| 主席 Chairmen | 王建安 Jianan WANG, 孙宁玲 Ningling SUN, 毛威 Wei MAO | ||
| 主持 Moderators | 孔祥清 Xiangqing KONG, 黄恺 Kai HUANG, 荆志成 Zhicheng JING, 徐标 Biao XU, 陈晓敏 Xiaomin CHEN, 蒋峻 Jun JIANG, 黄翯 He HUANG | ||
| 讨论嘉宾 Discussants | 王肖龙 Xiaolong WANG, 董鹏 Peng DONG, 郑泽琪 Zeqi ZHENG, 汪和贵 Hegui WANG, 叶泽兵 Zebing YE | ||
|
16:30-16:35 |
开场致辞 Opeing Remarks |
王建安Jianan WANG |
|
|
16:35-16:55 |
创无止境-ARNI共晶开创血压管理新格局 Innovation Knows No Bounds - ARNI Co-Crystal Creates a New Pattern of Blood Pressure Management |
高申 Shen GAO | |
|
16:55-17:15 |
研之有理-沙库巴曲阿利沙坦治疗高血压的关键性研究解读 Research Makes Sense - Key Study Interpretation of Sacubitril/Alisartan in the Treatment of Hypertension |
王继光 Jiguang WANG | |
|
17:15-17:55 |
洞见未来-新ARNI临床价值和发展战略讨论 Insight into the Future - Discussion on the Clinical Value and Development Strategy of New ARNI |
||
|
17:55-18:00 |
会议总结 Summary |
||